NCT06067893View on ClinicalTrials.gov

Low Dose Dexmedetomidine as a Postoperative Pain Adjunct

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Spinal FusionAdolescent Idiopathic Scoliosis
Interventions
DRUG

Dexmedetomidine

Patient receives dexmedetomidine for 48 hours post-operatively

DRUG

Normal Saline

Patient receives normal saline for 48 hours post-operatively

Trial Locations (1)

64108

Children's Mercy Hospital, Kansas City

All Listed Sponsors
lead

Children's Mercy Hospital Kansas City

OTHER